NJ State Employees Deferred Compensation Plan’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $568K | Hold |
|
|||||
|
2025
Q1 | $526K | Hold |
|
|||||
|
2024
Q4 | $536K | Hold |
|
|||||
|
2024
Q3 | $500K | Hold |
|
|||||
|
2024
Q2 | $421K | Hold |
|
|||||
|
2024
Q1 | $366K | Hold |
|
|||||
|
2023
Q4 | $357K | Hold |
|
|||||
|
2023
Q3 | $300K | Hold |
|
|||||
|
2023
Q2 | $361K | Hold |
|
|||||
|
2023
Q1 | $368K | Hold |
|
|||||
|
2022
Q4 | $334K | Sell |
|
|||||
|
2022
Q3 | $431K | Hold |
|
|||||
|
2022
Q2 | $446K | Hold |
|
|||||
|
2022
Q1 | $562K | Hold |
|
|||||
|
2021
Q4 | $772K | Hold |
|
|||||
|
2021
Q3 | $697K | Hold |
|
|||||
|
2021
Q2 | $656K | Hold |
|
|||||
|
2021
Q1 | $762K | Hold |
|
|||||
|
2020
Q4 | $497K | Hold |
|
|||||
|
2020
Q3 | $477K | Hold |
|
|||||
|
2020
Q2 | $559K | Hold |
|
|||||
|
2020
Q1 | $364K | Hold |
|
|||||
|
2019
Q4 | $521K | Hold |
|
|||||
|
2019
Q3 | $498K | Hold |
|
|||||
|
2019
Q2 | $571K | Hold |
|
|||||
|
2019
Q1 | $629K | Buy |
|
|||||
|
2018
Q4 | $407K | Buy |
|
|||||
|
2018
Q3 | $494K | Sell |
|
|||||
|
2018
Q2 | $414K | Sell |
|
|||||
|
2018
Q1 | $991K | Hold |
|
|||||
|
2017
Q4 | $822K | Buy |
|
|||||
|
2017
Q3 | $545K | Sell |
|
|||||
|
2017
Q2 | $809K | Hold |
|
|||||
|
2017
Q1 | $706K | Hold |
|
|||||
|
2016
Q4 | $677K | Hold |
|
|||||
|
2016
Q3 | $680K | Hold |
|
|||||
|
2016
Q2 | $795K | Hold |
|
|||||
|
2016
Q1 | $782K | Hold |
|
|||||
|
2015
Q4 | $723K | Hold |
|
|||||
|
2015
Q3 | $571K | Hold |
|
|||||
|
2015
Q2 | $673K | Hold |
|
|||||
|
2015
Q1 | $514K | Hold |
|
|||||
|
2014
Q4 | $355K | Hold |
|
|||||
|
2014
Q3 | $313K | Hold |
|
|||||
|
2014
Q2 | $415K | Hold |
|
|||||
|
2014
Q1 | $448K | Hold |
|
|||||
|
2013
Q4 | $351K | Hold |
|
|||||
|
2013
Q3 | $289K | Hold |
|
|||||
|
2013
Q2 | $249K | Buy |
|